← Back to SRPT

SAREPTA THERAPEUTICS INC financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 05/08/2026Mar 2026Filed 05/08/2026Dec 2025Filed 02/03/2026Sep 2025Filed 02/03/2026Jun 2025Filed 05/08/2026Mar 2025Filed 05/08/2026Dec 2024Filed 02/03/2026Sep 2024Filed 02/03/2026
$329$331$443$370$513$612$658$430
−$4.9$331−$412−$51$197−$448$159$34
−$0.05$2.88−$3.93−$0.50$1.89−$4.60$1.50$0.34
10512210010797100

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.